NCRIS Health welcomes the Australia RNA Blueprint
The NCRIS Health Group warmly welcomes the release of Australia’s RNA Blueprint by the Australian Department of Industry, Science and Resources. The NCRIS Health Group includes Bioplatforms Australia, EMBL Australia, National Imaging Facility, Phenomics Australia, Population Health Research Network and Therapeutic Innovation Australia. We are delighted that our advanced translational research infrastructure has been recognised […]
Therapeutic Innovation Australia and Phenomics Australia partnership reinforces commitment to address the medical products challenge
In partnership with Phenomics Australia (PA), Therapeutic Innovation Australia (TIA) is pleased to announce the successful recipients of the Pipeline Accelerator 2023-24 (Round 2). Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, TIA and PA support a network of national research infrastructure to address the medical products challenge in the 2021 National Research Infrastructure […]
TIA launches new RNA Products Capability
On May 24, 2024, TIA launched of its groundbreaking RNA Products Capability at UNSW, with the assistance of NSW Senator Tim Ayres, Chief Scientist Cathy Foley and UNSW Vice Chancellor Atilla Brungs. This new capability is supported by funding from the National Collaborative Research Infrastructure Strategy (NCRIS) of the Australian Department of Education. It aims […]
Funding boost from two state governments to enhance translational research infrastructure
Funding boost from two state governments to enhance translational research infrastructure TIA is thrilled to announce that we have secured over $5.5M in funding from the New South Wales (NSW) and Queensland Governments through the NCRIS Support Program and Research Infrastructure Co-Investment Fund (RICF), respectively. Under the NSW NCRIS Support Program, researchers and industries […]
